Gt Biopharma Stock Price on February 17, 2021

GTBP Stock  USD 4.43  0.06  1.37%   
Below is the normalized historical share price chart for GT Biopharma extending back to November 05, 1984. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of GT Biopharma stands at 4.43, as last reported on the 29th of March, with the highest price reaching 4.81 and the lowest price hitting 4.43 during the day.
IPO Date
22nd of September 2017
200 Day MA
7.1613
50 Day MA
4.9213
Beta
0.576
 
Black Monday
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in GTBP Stock, it is important to understand the factors that can impact its price. GT Biopharma retains Efficiency (Sharpe Ratio) of -0.12, which attests that the entity had a -0.12% return per unit of price deviation over the last 3 months. GT Biopharma exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out GT Biopharma's Information Ratio of (0.14), market risk adjusted performance of (0.68), and Coefficient Of Variation of (836.61) to validate the risk estimate we provide.
  
At this time, GT Biopharma's Other Stockholder Equity is relatively stable compared to the past year. As of 03/29/2024, Issuance Of Capital Stock is likely to grow to about 10.2 M, while Total Stockholder Equity is likely to drop slightly above 7.1 M. . As of 03/29/2024, Price Earnings Ratio is likely to grow to -1.29. In addition to that, Price To Sales Ratio is likely to drop to 2,293. GTBP Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.119

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsGTBP

Estimated Market Risk

 6.0
  actual daily
53
53% of assets are less volatile

Expected Return

 -0.71
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.12
  actual daily
0
Most of other assets perform better
Based on monthly moving average GT Biopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of GT Biopharma by adding GT Biopharma to a well-diversified portfolio.
Price Book
0.6031
Book Value
5.414
Enterprise Value
-9.9 M
Enterprise Value Ebitda
0.989
Shares Float
1.2 M

GT Biopharma Valuation on February 17, 2021

It is possible to determine the worth of GT Biopharma on a given historical date. On February 17, 2021 GTBP was worth 2.71 at the beginning of the trading date compared to the closed value of 81.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of GT Biopharma stock. Still, in general, we apply an absolute valuation method to find GT Biopharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of GT Biopharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against GT Biopharma's related companies.
 Open High Low Close Volume
03/15/2022
  2.71    81.00    81.00    81.00    1,857  
  2.69    82.20    82.20    82.20    3,029  
Backtest GT Biopharma  |  GT Biopharma History  |  GT Biopharma Valuation Next  
Open Value
2.71
81.0
Closing Value
20.72
Upside

GT Biopharma Trading Date Momentum on February 17, 2021

The event impact on price volatility cannot be determined at this time. Please check this event after some time to allow current data to be analyzed.

GT Biopharma Fundamentals Correlations and Trends

By evaluating GT Biopharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among GT Biopharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. GTBP financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About GT Biopharma Stock history

GT Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for GTBP is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in GT Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing GT Biopharma stock prices may prove useful in developing a viable investing in GT Biopharma
Last ReportedProjected for 2024
Common Stock Shares Outstanding1.3 M1.3 M
Net Loss-52.2 M-54.8 M

GT Biopharma Stock Technical Analysis

GT Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of GT Biopharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of GT Biopharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

GT Biopharma Period Price Range

Low
March 15, 2022
78.29  2,889%
High

 2.71 

     

 81.00 

GT Biopharma March 29, 2024 Market Strength

Market strength indicators help investors to evaluate how GT Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading GT Biopharma shares will generate the highest return on investment. By undertsting and applying GT Biopharma stock market strength indicators, traders can identify GT Biopharma entry and exit signals to maximize returns

GT Biopharma Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for GT Biopharma's price direction in advance. Along with the technical and fundamental analysis of GTBP Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of GTBP to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether GT Biopharma is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if GTBP Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Gt Biopharma Stock. Highlighted below are key reports to facilitate an investment decision about Gt Biopharma Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GT Biopharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
To learn how to invest in GTBP Stock, please use our How to Invest in GT Biopharma guide.
Note that the GT Biopharma information on this page should be used as a complementary analysis to other GT Biopharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Complementary Tools for GTBP Stock analysis

When running GT Biopharma's price analysis, check to measure GT Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GT Biopharma is operating at the current time. Most of GT Biopharma's value examination focuses on studying past and present price action to predict the probability of GT Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GT Biopharma's price. Additionally, you may evaluate how the addition of GT Biopharma to your portfolios can decrease your overall portfolio volatility.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Is GT Biopharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GT Biopharma. If investors know GTBP will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GT Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(9.12)
Return On Assets
(0.55)
Return On Equity
(0.79)
The market value of GT Biopharma is measured differently than its book value, which is the value of GTBP that is recorded on the company's balance sheet. Investors also form their own opinion of GT Biopharma's value that differs from its market value or its book value, called intrinsic value, which is GT Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GT Biopharma's market value can be influenced by many factors that don't directly affect GT Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GT Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if GT Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GT Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.